d-alpha tocopherol has been researched along with Acute Radiation Syndrome in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (76.92) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelsalam, RM; Attia, AS; El-Ghazaly, MA; El-Sabbagh, WA; Gheita, HA | 1 |
| Fatanmi, OO; Posarac, A; Singh, PK; Singh, VK; Wise, SY | 1 |
| Fatanmi, OO; Rao, VA; Rosen, E; Singh, VK; Wise, SY | 1 |
| Basnakian, AG; Fatanmi, OO; Garg, S; Garg, TK; Hauer-Jensen, M; Miousse, IR; Savenka, AV; Singh, VK; Wise, SY | 1 |
| Seed, TM; Singh, VK | 1 |
| Depeš, D; Falk, M; Hofer, M; Hoferová, Z | 1 |
| Cheema, AK; Fatanmi, OO; Hinzman, CP; Mehta, KY; Singh, VK; Wise, SY; Wolff, J | 1 |
| Fatanmi, OO; Fornace, AJ; Laiakis, EC; Pannkuk, EL; Singh, VK | 1 |
| Beattie, LA; Seed, TM; Singh, VK | 1 |
| Fatanmi, OO; Ghosh, SP; Gulani, J; Hauer-Jensen, M; Hendrickson, H; Kulkarni, S; Kumar, KS; Newman, VL; Romaine, PL; Singh, VK; Wise, SY | 1 |
| Hauer-Jensen, M; Singh, VK | 1 |
| Berg, AN; Fatanmi, OO; Newman, VL; Romaine, PL; Singh, VK; Verma, A; Wise, SY | 1 |
| Biswas, S; Bostanian, LA; Ghosh, SP; Graves, RA; Kumar, VP; Ledet, GA; Mandal, TK; Mitchner, DM; Parker, TM | 1 |
3 review(s) available for d-alpha tocopherol and Acute Radiation Syndrome
| Article | Year |
|---|---|
Combining Pharmacological Countermeasures to Attenuate the Acute Radiation Syndrome-A Concise Review.
Topics: Acute Radiation Syndrome; Amifostine; Animals; Dinoprostone; Drug Administration Schedule; Drug Combinations; Drug Synergism; Granulocyte Colony-Stimulating Factor; Humans; Metformin; Misoprostol; Radiation Injuries, Experimental; Radiation-Protective Agents; Vitamin E | 2017 |
Vitamin E: tocopherols and tocotrienols as potential radiation countermeasures.
Topics: Acute Radiation Syndrome; Animals; Critical Care; Humans; Radiation Protection; Radiation-Protective Agents; Tocopherols; Tocotrienols; Treatment Outcome; Vitamin E | 2013 |
γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.
Topics: Acute Radiation Syndrome; Animals; Blood Platelets; Chromans; Cytokines; Drug Evaluation, Preclinical; Humans; Neutrophils; Radiation-Protective Agents; Vitamin E | 2016 |
10 other study(ies) available for d-alpha tocopherol and Acute Radiation Syndrome
| Article | Year |
|---|---|
Promising role of filgrastim and α-tocopherol succinate in amelioration of gastrointestinal acute radiation syndrome (GI-ARS) in mice.
Topics: Acute Radiation Syndrome; alpha-Tocopherol; Animals; Antioxidants; Caspase 3; Cyclooxygenase 2; Filgrastim; Gastrointestinal Tract; Hematologic Agents; Male; Mice; Nitric Oxide Synthase Type II; Tumor Suppressor Protein p53; Whole-Body Irradiation | 2019 |
Radioprotective properties of tocopherol succinate against ionizing radiation in mice.
Topics: Acute Radiation Syndrome; alpha-Tocopherol; Animals; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Lethal Dose 50; Male; Mice; Radiation Tolerance; Radiation-Protective Agents; Survival Rate; Whole-Body Irradiation | 2013 |
Gamma-tocotrienol, a radiation countermeasure, reverses proteomic changes in serum following total-body gamma irradiation in mice.
Topics: Acute Radiation Syndrome; Animals; Chromans; Gamma Rays; Glycoproteins; Mice; Proteomics; Radiation-Protective Agents; Vitamin E; Whole-Body Irradiation | 2022 |
Effects of Gamma-Tocotrienol on Intestinal Injury in a GI-Specific Acute Radiation Syndrome Model in Nonhuman Primate.
Topics: Acute Radiation Syndrome; Animals; Chromans; Disease Models, Animal; Intestines; Ki-67 Antigen; Macaca mulatta; Radiation-Protective Agents; Vitamin E | 2022 |
Development of gamma-tocotrienol as a radiation medical countermeasure for the acute radiation syndrome: current status and future perspectives.
Topics: Acute Radiation Syndrome; Animals; Humans; Medical Countermeasures; Mice; Radiation-Protective Agents; Vitamin E | 2023 |
A Metabolomic and Lipidomic Serum Signature from Nonhuman Primates Administered with a Promising Radiation Countermeasure, Gamma-Tocotrienol.
Topics: Acute Radiation Syndrome; Animals; Antioxidants; Biological Availability; Cholecalciferol; Cholic Acid; Chromans; Docosahexaenoic Acids; Female; Humans; Lactic Acid; Lipid Metabolism; Macaca mulatta; Male; Metabolome; Radiation-Protective Agents; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vitamin E | 2017 |
A Metabolomic Serum Signature from Nonhuman Primates Treated with a Radiation Countermeasure, Gamma-tocotrienol, and Exposed to Ionizing Radiation.
Topics: Acute Radiation Syndrome; Animals; Biomarkers; Chromans; Dose-Response Relationship, Radiation; Female; Macaca mulatta; Male; Metabolome; Metabolomics; Pilot Projects; Radiation Exposure; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiation, Ionizing; Vitamin E | 2018 |
Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.
Topics: Acute Radiation Syndrome; Animals; Chromans; Cobalt Radioisotopes; Disease Models, Animal; Dose-Response Relationship, Radiation; Gamma Rays; Humans; Macaca mulatta; Primates; Radiation-Protective Agents; Thrombocytopenia; United States; Vitamin E; Whole-Body Irradiation | 2016 |
Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure.
Topics: Acute Radiation Syndrome; Animals; Cell Movement; Cells, Cultured; Chromans; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Male; Mice; Radiation-Protective Agents; Treatment Outcome; Vitamin E | 2016 |
Development of Orally Administered γ-Tocotrienol (GT3) Nanoemulsion for Radioprotection.
Topics: Acute Radiation Syndrome; Administration, Oral; Animals; Chromans; Drug Stability; Emulsions; Lactose; Male; Mice; Radiation-Protective Agents; Vitamin E | 2016 |